FSCN1 and serous adenocarcinoma: Another study also reported upregulated expression of FSCN1, cortactin, and EGFR in TMAs of four ovarian carcinomas (serous carcinoma, mucinous carcinoma, endometrioid adenocarcinoma, and clear cell carcinoma) [139].